Top compounds associated with response to TMEM261


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.055 0.1
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.055 0.1
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.054 0.1
mRNA thalidomide CTRPv2 pan-cancer AAC -0.088 0.1
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.052 0.1
mRNA THZ-2-49 GDSC1000 pan-cancer AAC 0.048 0.1
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.1
mRNA OSI-027 GDSC1000 pan-cancer AAC 0.051 0.1
mRNA 17-AAG CCLE pan-cancer AAC -0.075 0.1
Download CSV